Background: The presence of multimorbidity in the family practice setting is as evident as it is hard to measure. Objective: The objective of this study was to describe the differences in the prevalence of multimorbidity in a single primary care population, through the use of the only two available lists of chronic conditions based on the International Classification for Primary Care coding system. Methods: This is a cross-sectional, analytical study. Secondary analysis of existing chronic conditions data involved 1279 women and 714 men attending primary care centres in mainland Portugal. Multimorbidity was measured by the presence in each patient of both ≥2 and ≥3 chronic conditions, from both a list of 147 conditions and another list of 75 conditions. Logistic regression analyses were conducted to study the association of multimorbidity with sex, age, education and income by the type of list of chronic conditions. Results: Multimorbidity prevalence estimates are modified by (i) the number of chronic conditions included in the lists used and (ii) the number of conditions necessary to define the cut-off for multimorbidity. The use of different lists of conditions modifies not only the multimorbidity prevalence estimates but also the evaluation of the determinants of multimorbidity. Conclusions: The use of different lists of chronic conditions produces different research results. Even the use of lists designed to be more general practice-oriented may underestimate the frequency of multimorbidity by limiting the number of conditions considered. Further research is still needed to grasp the full implications of using different lists of chronic conditions in multimorbidity research.
Introduction
The presence of multimorbidity-coexistence of more than one chronic condition in a person (1)-in the family practice/primary care setting is as evident (2) as it is hard to measure (3). The negative impact of multimorbidity on patients is well known (4) in terms of high mortality (5) , poor physical function (6) , low quality of life (7) and high health care costs (8) .
In a recent literature review (9) , which included primary care data from 12 countries, multimorbidity prevalence was found to be between 12.9% and 95.1% (9) . The wide difference of the published results is due to the characteristics of the studied populations and the definition of multimorbidity in such studies (10, 11) . Although there has been a growing theoretical reasoning on the definition of multimorbidity during the past years, there is still no consensual definition (12) . The number of chronic conditions collected and the number of conditions for which the person is considered to have multimorbidity vary between studies (9). These factors make comparisons between studies difficult.
Furthermore, most of the published measures of multimorbidity use disease classification systems that do not reflect the health problems found in primary care. The International Classification of Primary Care (ICPC) is recognized by the World Health Organization as an ideal classification system for primary care and is now widely used internationally (13) . Currently, it is in its second version: ICPC-2 (13) .
A recent study that compared prevalence estimates of multimorbidity (3) noticed that the list of 147 chronic conditions developed by O'Halloran et al. (14) (based on ICPC-2 coding system) is a good reference point for estimating the prevalence of multimorbidity (3). This list originated from a literature review process, specifically for the Australian general practice setting, and although it has the purpose of measuring the prevalence of chronic conditions (14) it was not developed within the context of multimorbidity. Nonetheless, it was used in several multimorbidity studies. For example, in Portugal, the prevalence of multimorbidity (2+ chronic conditions) is estimated to be 72.7% among adult patients attending primary care consultations (15) , by using O'Halloran et al.'s list (14) .
In 2016, more than 10 years after the publication of the aforementioned list, and because the standards for calculating and reporting multimorbidity are still lacking, N'Goran et al. (16) published, in the same journal, the second list of chronic conditions based on the ICPC-2 coding system. This list has gathered 75 chronic conditions thought to be the most relevant in the context of multimorbidity, after obtained consensus from a large panel of Swiss family physicians (16 (17) . These are the only two available lists of chronic conditions based on the ICPC-2 coding system. Most importantly, N'Goran et al.'s list was the first to be developed within the context of multimorbidity (16) .
This study used cross-sectional data from an existing primary care sample patient population in Portugal, published in 2015 (15) . In this previous study, multimorbidity was measured at 2+ and 3+ conditions per patient using O'Halloran et al. ' s list. The current study is the next step to compare the results from that study with measurements using the new list of N'Goran et al. This study tests the extent to which the number of conditions in the lists affects the outcome of the multimorbidity measure. Using the same target population allows a better, less biased comparison than relating different lists in different population samples. We hypothesize that the prevalence estimates for multimorbidity in family practice are vulnerable to the chronic conditions comprised in the lists.
Methods
Family practice data were extracted from the first phase of the MM-PT project (multimorbidity in primary care in Portugal), a cross-sectional study conducted by the authors, from October 2013 to December 2014, in the five mainland Portuguese Healthcare Administrative Regions (15) . Full methods of the MM-PT project were published elsewhere (18) . Over the study period, enrolled GPs recorded demographic and clinical variables (chronic conditions) from 1993 adult patients (1279 women, 714 men) that attended primary care consultations and that gave formal consent (mean = 28.9 patients recruited per GP) (15) .
The original study was performed in accordance with the ethical standards of the Declaration of Helsinki (19) and received institutional ethics committee approval.
For the current study, demographic variables including sex, age, educational level and income were extracted for each patient from the MM-PT project database. Data on chronic conditions, coded according to the ICPC-2 (13), were also obtained. Multimorbidity was defined as the co-occurrence of (i) ≥2 chronic conditions and (ii) ≥3 chronic conditions in the same individual. For comparison purposes, two lists of chronic conditions based on ICPC-2 coding system (13) were used (i) 147 conditions list developed by O'Halloran et al. (14) and (ii) 75 conditions list developed by N'Goran et al. (16) .
Data analyses were done using the IBM SPSS Statistics for Windows, Version 21.0 (IBM Corporation, Armonk, NY). Descriptive statistics were used to summarize variables: mean and standard deviation (SD) for numerical variables and absolute and relative frequencies for categorical variables. Chi-square tests for group comparisons were performed between the prevalence of multimorbidity for both lists across sample's characteristics. Multiple binary logistic regression analysis for the presence of multimorbidity (for both lists) was conducted using the variables sex, age, education and income and a stepwise selection method. P values of <0.05 were deemed statistically significant. Table 1 shows the demographic characteristics of the study population and the global prevalence of multimorbidity. The sample was aged between 18 and 95 years (mean ± SD = 56.3 ± 17.5), 64.2% were women. The two lists considered in the current study, which have a different number of chronic conditions, affected the estimated prevalence of multimorbidity-or more exactly-if one considers N'Goran et al.'s list of 75 chronic conditions, the average number of conditions present in the sample is reduced by half, compared with (Table 1) . Table 2 Table 3 shows the association of multimorbidity with sex, age, educational level and income by type of list of chronic conditions. In all cases, old age and low education increased the likelihood of multimorbidity (P < 0.05). Male gender and low income was associated with higher multimorbidity only when using N'Goran et al.'s list (P <0.05).
Results

Discussion
Strengths of the study
To the extent of our knowledge, the present study is the first to measure multimorbidity by comparing the only two prevailing lists of chronic conditions based on the ICPC-2 (13) coding system-O'Halloran et al.'s list and N'Goran et al.'s list-on the same target population sample. The major strength of this study is that by using only one sample, the compared prevalence estimates of multimorbidity were not affected by different data collection methods. The study's results will be useful for further epidemiology research in primary care and family medicine settings.
Overall findings and relationship with other studies
The current study seems to be consistent with previous research (11) which found that multimorbidity prevalence estimates are modified by (i) the number of chronic conditions included in the lists used and (ii) the number of conditions necessary to define the cut-off for multimorbidity (11) . The higher the number of chronic conditions in the list, the higher the prevalence of multimorbidity found (20) . In relation to the cut-off in number of chronic conditions, a count of 3+ conditions results in a lower prevalence of multimorbidity (20) , for both lists of chronic conditions.
The similarity found in the prevalence estimates of multimorbidity between the 2+ N'Goran et al.'s list (50.2%) and the 3+ O'Halloran et al.'s list (57.2%), which is maintained throughout the different sociodemographic characteristics, may suggest that when studying similar populations, multimorbidity measured by 2+ chronic conditions from a list of a lower number of conditions assessed may be comparable to multimorbidity measured by 3+ conditions from a list of a higher number of conditions, especially in younger age groups. These results are of importance as the number of chronic conditions used between published studies varies and so no direct comparisons can be made so far (9, 10) .
The use of different lists of conditions modifies not only the multimorbidity prevalence estimates but also the evaluation of the determinants of multimorbidity. Older age, gender and lower socioeconomic status are known determinants of multimorbidity (9) . In the present study, the use of N'Goran et al.'s list-a list developed to characterize the variety and complexity of patients found in the clinical settings of family doctors (17)-revealed determinants of multimorbidity that were not present when using O'Halloran et al.'s list. This may suggest that some conditions included in these lists may contribute to the likelihood of multimorbidity at a higher extent than others. Nonetheless, whether this is a real difference between the two lists, or the consequence of the sample's characteristics, will remain the subject of future studies.
A note of caution is due: as stated in previous research, N'Goran et al.'s list does not take into consideration some chronic condition commonly found in the context of multimorbidity (17); the current study showed that this affects the identification of the most common conditions in the sample (see Table 2 ). Thus, the use of N'Goran et al.'s list in future prevalence studies will have to take this limitation into consideration and their findings will have to be carefully interpreted. For some authors (3), the exclusion of conditions that require medical treatment and the use of lists with limited number of conditions that may not reflect the full heterogeneity of primary care can create biased results.
Limitations of the study
The present study has some limitations inherent to secondary analysis of existing data (21) . The available data were not collected specifically for the current study and variables could not be modified.
Nevertheless, as the authors were familiar with the existing data and no extra variables were needed, this was not considered to be a problem. Its low cost was a significant advantage for an unfunded research such as this.
Conclusion
The current study contributes to increase the understanding of the epidemiology of multimorbidity. 
